FHIR R4 ResearchSubject API

(0 reviews)
A physical entity which is the primary unit of operational and/or administrative interest in a study.

home

Overview

This asset is a component of MuleSoft Accelerator for Healthcare.

MuleSoft Accelerator for Healthcare enables healthcare providers to unlock critical patient data to build a patient 360 within Salesforce Health Cloud, faster and easier than ever before. The solution includes pre-built APIs, connectors, integration templates, and prescriptive end-to-end reference architecture to bring patient demographics information and COVID-19 test results from any EHR into Health Cloud using HL7 V2 or FHIR standards.

The solution also provides a library of United States Core Data for Interoperability (USCDI) and FHIR R4 resources to help healthcare developers adhere to interoperability needs and jumpstart the development of healthcare digital transformation initiatives.

Use case covered

A research subject is the entity of interest in a research study, typically a human being or an animal, but can also be a device, group of humans or animals, or a tissue sample. The ResearchSubject resource describes essential information about the subject, including the gender, birthdate, study, study arm, consent status, and other key items. Human research subjects are usually not traceable to a particular person to protect the subject’s privacy.

The ResearchSubject resource is used in the following research activities:

  • Consent and registration to a research study
  • Exposure to test therapy
  • Assessment of test therapy results
  • Reporting of adverse events

This API uses FHIR R4 ResearchSubject Library.

More information about FHIR R4 ResearchSubject specification can be found here.


Reviews

TypeREST API
OrganizationMuleSoft
Published by
MuleSoft Organization
Published onJul 23, 2020
Asset overview

Asset versions for 1.0.x

Asset versions
VersionActions
1.0.0

Categories

Accelerator
HealthcareNo values left to add
Industry Vertical
HealthcareNo values left to add

Tags